Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma

BACKGROUND: Nivolumab and pembrolizumab have not been directly compared in clinical trials, and the aim of this study is to investigate the efficacy and safety of nivolumab versus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) in real-world practice. METHODS: We retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Hao, Tsai, Ching-Hua, Chen, Yen-Yang, Wang, Chih-Chi, Wang, Jing-Houng, Hung, Chao-Hung, Kuo, Yuan-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463359/
https://www.ncbi.nlm.nih.gov/pubmed/37644388
http://dx.doi.org/10.1186/s12885-023-11298-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463359/
https://www.ncbi.nlm.nih.gov/pubmed/37644388
http://dx.doi.org/10.1186/s12885-023-11298-z

Ejemplares similares